Experimental Hematology Group - VHIO

VHIO’s Experimental Hematology Group conducts translational, pre-clinical and clinical research on hematological neoplasms of both lymphoid and myeloid origin. Our research team is composed of hematologists and biological scientists who work closely together to design, conduct and lead our programs.

Nirmatrelvir/ritonavir in COVID-19 patients with haematological

PDF) Real‐world evidence of tisagenlecleucel for the treatment of

Hematologia - Hospital Universitari Vall d'Hebron (@Hemato_Vhebron

ORAL PRESENTATIONS - 2021 - Hematological Oncology - Wiley Online

Hematologia - Hospital Universitari Vall d'Hebron (@Hemato_Vhebron

Hereditary Cancer Genetics Group - VHIO

Cancer Genomics Group - VHIO

Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in

Cancers, Free Full-Text

IJMS, Free Full-Text

Upper Gastrointestinal & Endocrine Tumors - VHIO

Experimental Hematology Group - VHIO